3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 25 0 0 0 0 0 0 0999 V2000
0.7968 1.4693 -1.1404 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2835 -1.5865 -0.0353 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4184 -1.1696 -0.6805 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8225 0.8304 0.8418 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.5279 1.3778 0.8845 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6372 0.4935 0.4242 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7481 1.2411 0.0656 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5404 0.9501 -0.5359 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7715 -0.7901 0.9534 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1431 0.6238 0.2951 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5778 0.1231 -0.9667 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8089 -1.6171 0.5224 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7121 -1.1603 -0.4375 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3634 -0.7856 -0.1906 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8340 2.4307 0.8276 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.3336 1.1979 1.9491 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.4458 1.9473 -0.9575 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.0727 -1.1581 1.7000 H 0 0 0 0 0 0 0 0 0 0 0 0
1.6884 0.6388 1.8301 H 0 0 0 0 0 0 0 0 0 0 0 0
3.8601 0.8336 1.0938 H 0 0 0 0 0 0 0 0 0 0 0 0
3.2995 1.3097 -0.5426 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.2808 0.4784 -1.7146 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.9131 -2.6168 0.9338 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.5196 -1.8044 -0.7732 H 0 0 0 0 0 0 0 0 0 0 0 0
2.4514 -2.4969 -0.3596 H 0 0 0 0 0 0 0 0 0 0 0 0
1 7 2 0 0 0 0
2 14 1 0 0 0 0
2 25 1 0 0 0 0
3 14 2 0 0 0 0
4 7 1 0 0 0 0
4 10 1 0 0 0 0
4 19 1 0 0 0 0
5 6 1 0 0 0 0
5 7 1 0 0 0 0
5 15 1 0 0 0 0
5 16 1 0 0 0 0
6 8 2 0 0 0 0
6 9 1 0 0 0 0
8 11 1 0 0 0 0
8 17 1 0 0 0 0
9 12 2 0 0 0 0
9 18 1 0 0 0 0
10 14 1 0 0 0 0
10 20 1 0 0 0 0
10 21 1 0 0 0 0
11 13 2 0 0 0 0
11 22 1 0 0 0 0
12 13 1 0 0 0 0
12 23 1 0 0 0 0
13 24 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
2-[(2-phenylacetyl)amino]acetic acid
4.2 InChl
InChI=1S/C10H11NO3/c12-9(11-7-10(13)14)6-8-4-2-1-3-5-8/h1-5H,6-7H2,(H,11,12)(H,13,14)
4.3 InChlKey
UTYVDVLMYQPLQB-UHFFFAOYSA-N
4.4 Canonical SMILES
C1=CC=C(C=C1)CC(=O)NCC(=O)O
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病